Cal­i­co, De­nal­i's ALS drugs miss pri­ma­ry ob­jec­tives in bas­ket study

A bas­ket study for ex­per­i­men­tal ALS treat­ments record­ed a pair of ad­di­tion­al fail­ures on Mon­day from two promi­nent com­pa­nies.

New da­ta from Google’s longevi­ty play …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER